Vorinostat Withdrawn Phase 2 Trials for Non-Hodgkin's Lymphoma (NHL) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00837174Relapsed and/or Refractory Non-Hodgkin Lymphoma Study